Royalty Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 20, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	19,433	16,564	11,377	12,548	17,514	17,254
Market Cap Growth	34.75%	45.59%	-9.33%	-28.36%	1.51%	-11.18%
Enterprise Value	27,766	27,754	20,459	21,764	25,795	26,699
Last Close Price	45.36	38.64	25.51	28.09	39.52	39.85
PE Ratio	25.46	21.71	13.36	11.10	395.20	26.74
Forward PE	8.96	7.70	6.10	7.47	10.32	13.00
PEG Ratio	0.72	0.79	2.14	2.65	0.94	1.12
PS Ratio	8.17	6.96	5.03	5.33	7.83	7.54
PB Ratio	3.00	2.56	1.64	1.92	3.11	2.99
P/TBV Ratio	3.95	3.37	2.18	2.60	3.08	2.86
P/FCF Ratio	-	6.65	4.11	4.20	8.17	8.55
P/OCF Ratio	7.81	6.65	4.11	4.20	8.17	8.55
EV/Sales Ratio	11.68	11.67	9.04	9.24	11.53	11.66
EV/EBITDA Ratio	17.76	17.75	15.83	14.59	84.00	18.66
EV/EBIT Ratio	17.80	17.80	15.83	14.59	84.00	18.66
EV/FCF Ratio	-	11.15	7.39	7.28	12.03	13.23
Debt / Equity Ratio	0.88	0.88	0.64	0.61	0.64	0.69
Debt / EBITDA Ratio	5.73	5.73	5.89	4.11	23.18	4.96
Debt / FCF Ratio	3.60	3.60	2.75	2.05	3.32	3.52
Net Debt / Equity Ratio	1.29	1.29	0.96	0.87	0.96	0.86
Net Debt / EBITDA Ratio	5.33	5.33	5.17	3.79	17.52	3.48
Net Debt / FCF Ratio	3.35	3.35	2.41	1.89	2.51	2.47
Asset Turnover	0.13	0.13	0.13	0.14	0.13	0.14
Quick Ratio	1.02	1.02	0.76	3.09	1.52	12.80
Current Ratio	2.40	2.40	1.44	7.90	2.19	16.81
Return on Equity (ROE)	13.20%	13.20%	13.03%	17.34%	2.33%	12.32%
Return on Assets (ROA)	8.24%	8.24%	7.47%	8.99%	1.79%	8.53%
Return on Invested Capital (ROIC)	8.60%	8.60%	7.79%	9.64%	2.02%	9.73%
Return on Capital Employed (ROCE)	8.68%	8.68%	7.79%	9.36%	1.86%	8.66%
Earnings Yield	3.97%	4.61%	7.49%	9.01%	0.25%	3.74%
FCF Yield	-	15.03%	24.34%	23.81%	12.24%	11.69%
Dividend Yield	2.07%	2.28%	3.29%	2.85%	1.93%	1.73%
Payout Ratio	50.24%	49.06%	43.83%	31.58%	778.21%	46.02%
Buyback Yield / Dilution	7.41%	7.41%	2.02%	2.43%	0.00%	0.00%
Total Shareholder Return	9.48%	9.69%	5.31%	5.28%	1.93%	1.73%

Updated Feb 11, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q